SD Biosensor, Inc. (KRX:137310)
South Korea · Delayed Price · Currency is KRW 8,420.00
+70.00 (0.84%)
At close: Apr 30, 2026
SD Biosensor Revenue
In the year 2025, SD Biosensor had annual revenue of 710.58B KRW with 2.30% growth. SD Biosensor had revenue of 194.57B in the quarter ending December 31, 2025, with 8.02% growth.
Revenue
710.58B
Revenue Growth
+2.30%
P/S Ratio
1.41
Revenue / Employee
1.23B
Employees
576
Market Cap
998.77B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 710.58B | 16.01B | 2.30% |
| Dec 31, 2024 | 694.57B | 38.90B | 5.93% |
| Dec 31, 2023 | 655.68B | -2,276.32B | -77.64% |
| Dec 31, 2022 | 2.93T | 2.04B | 0.07% |
| Dec 31, 2021 | 2.93T | 1.24T | 73.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4.81T |
| Celltrion | 4.16T |
| Daewoong | 2.07T |
| Chong Kun Dang Pharmaceutical | 1.69T |
| Samsung Epis Holdings | 1.51T |
| DongKook Pharmaceutical | 926.88B |
| ALTEOGEN | 215.86B |
| MEDIPOST | 73.66B |